Eslicarbazepine (All indications) updated on 04-22-2025

Table   Graphic     exposition period:

Congenital malformations
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
All congenital malformations (majors, minors, majors and minors, or unspecified)5.49 [0.90, 33.67]0%3 studies13818not evaluable ROB-
Major congenital malformations5.49 [0.90, 33.67]0%3 studies13818not evaluable ROB-

- About - Master protocol - Browse exposition - RSS - Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons